CareFusion

Middleton, WI, United States

CareFusion

Middleton, WI, United States
SEARCH FILTERS
Time filter
Source Type

News Article | May 1, 2017
Site: www.prweb.com

OrthAlign, Inc., a privately held U.S.-based medical device and technology company providing orthopedic surgeons with advanced precision technologies, announced today the executive appointment of Mike Bushlack as Chief Financial Officer and the promotion of James Young Kim as Vice President and General Manager of International. Mike Bushlack comes to OrthAlign with over 15 years of financial leadership experience in the medical device industry, working with early growth stage and large multi-national companies. Prior to joining OrthAlign, Mike was Chief Financial Officer of Blue Belt Technologies, Inc. and held executive financial leadership and business development roles at ev3 Inc., Covidien, and Medtronic, garnering a proven track record of partnering with business teams to develop and implement strategic plans and financial processes and focus investments to drive growth and enhance entity value. Mike began his career at KPMG LLP in Minneapolis, where he was a Senior Manager. James Kim has over 12 years of strategic marketing and sales experience in the medical and healthcare industry, responsible for strategic planning, product and brand management, product development, and multiple launch and global commercialization assignments. Since October 2013, James served as OrthAlign's Vice President of Sales and Marketing, helping lead the organization through an important growth period, including expansion of OrthAlign technology into key international markets. Prior to joining OrthAlign, James served in key marketing roles with Allergan, CareFusion, and Johnson & Johnson, successfully managing the Natrelle®, Pyxis®, and OneTouch® brands, respectively. James received an MBA from the University of Southern California’s Marshall School of Business. “The executive appointments of Mike and James are key elements in our continued efforts to successfully expand our customer reach, portfolio of products, and focus in providing world class customer service to our surgeons, hospitals, and surgery centers across the globe,” said Eric B. Timko, OrthAlign’s Chief Executive Officer and Chairman. “We are energized and excited about the growth opportunities before us and are heavily focused on our strategic initiatives as one of the leading technology companies in orthopaedics.” OrthAlign is a privately held medical device and technology company, developing advanced technologies that deliver healthier and more pain-free lifestyles to joint replacement patients, globally. We provide healthcare professionals with cutting edge, computer-assisted surgical tools that seamlessly and cost-effectively deliver vital data and clinical results to optimize outcomes for our patients. For more information regarding OrthAlign, please visit http://www.orthalign.com. “ORTHALIGN®, ORTHALIGN PLUS®, KNEEALIGN®, KNEEALIGN® 2, HIPALIGN®, and UNIALIGN™ are registered trademarks of OrthAlign, Inc.”


Global Analgesic Infusion Pumps Sales-Market to Witness Steady Growth During the Period 2017-2022 The study observes that Global infusion pumps market has experienced a significant growth in past few years due to increasing patient pool and improvement in the healthcare facilities. Albany, NY, April 19, 2017 --( Request Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1037613 Infusion pumps are the medical devices that are used for delivering therapeutic drugs into patient’s body. Likewise, analgesic infusion pumps are devices used for pain management that deliver analgesic drugs into a patient’s body. These pumps are widely used to relieve pain in patients especially those who have undergone a surgery and patients having severe pain. Analgesic drug delivery provides relief from chronic disorders such as failed back syndrome, hypertension, complex regional pain syndrome, pneumonia, tachycardia, myocardial infarction, etc. Firstly, the study offers a precise market overview of analgesic infusion pumps market along with its classification and application. The study observes that Global infusion pumps market has experienced a significant growth in past few years due to increasing patient pool and improvement in the healthcare facilities. With the wide availability of analgesic fusion pumps in various types, the sales are also increasing. The market has been segmented by product type into: Self-Controlled Analgesic Pumps Non-Controlled Analgesic Pump The main focus of the study to analyze the market future growth, by considering the overall sales (K Units), revenue (Million USD) market share and growth rates of Analgesic Infusion Pumps in regions, such as Europe, United States, Southeast Asia, China, Japan and India. Moreover, this report focuses on the status and stance for major applications/end users, market share, sales volume and growth rate of these pumps in its major applications, such as Hospitals, Clinics and others. According to the study findings, due to a number of factors like growing prevalence of chronic diseases along with increasing geriatric population, increasing adoption of portable infusion pumps to reduce hospital expenditure and rapid increase in surgical procedural volumes, the global market has gained huge impetus in the year 2016. The researchers also estimated that the market will show a rapid growth in USD million by the end of 2022. Some of the major companies dealing in the analgesic infusion pumps market are: Smiths Medical Taizhou Pinqing Braun Terumo Hospira Woo Young Medical Baxter KD Scientific Fresenius Kabi Medtronic CareFusion (BD) Summit Medical Products Browse Full Report With TOC: http://www.marketresearchhub.com/report/global-analgesic-infusion-pumps-sales-market-report-2017-report.html In the end, the report includes major sections which provide analysis on manufacturing cost, industrial chain, marketing strategy, market effect factors and the overall growth forecast for the period of 2017-2022. About Market Research Hub Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps. MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients. Contact Us 90 State Street Albany, NY 12207 United States Toll Free: 866-997-4948 (US-Canada) Tel: +1-518-621-2074 Email: press@marketresearchhub.com Follow us on: Twitter: twitter.com/MktResearchHub LinkedIn: www.linkedin.com/company/market-research-hub Facebook: www.facebook.com/MarketResearchHub/ Albany, NY, April 19, 2017 --( PR.com )-- The rapidly expanding global market of analgesic pumps, is the focus of the latest study added to the massive repository of Market Research Hub (MRH). The report is titled as “Global Analgesic Infusion Pumps Sales Market” Report 2017 which encapsulates various key information of the global market, by analyzing it into major key regions. The study findings display that, the increasing demand for infusion pumps in developing countries and the rising acceptance of specialty infusion systems offer significant growth openings in the market.Request Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1037613Infusion pumps are the medical devices that are used for delivering therapeutic drugs into patient’s body. Likewise, analgesic infusion pumps are devices used for pain management that deliver analgesic drugs into a patient’s body. These pumps are widely used to relieve pain in patients especially those who have undergone a surgery and patients having severe pain. Analgesic drug delivery provides relief from chronic disorders such as failed back syndrome, hypertension, complex regional pain syndrome, pneumonia, tachycardia, myocardial infarction, etc.Firstly, the study offers a precise market overview of analgesic infusion pumps market along with its classification and application. The study observes that Global infusion pumps market has experienced a significant growth in past few years due to increasing patient pool and improvement in the healthcare facilities. With the wide availability of analgesic fusion pumps in various types, the sales are also increasing.The market has been segmented by product type into:Self-Controlled Analgesic PumpsNon-Controlled Analgesic PumpThe main focus of the study to analyze the market future growth, by considering the overall sales (K Units), revenue (Million USD) market share and growth rates of Analgesic Infusion Pumps in regions, such as Europe, United States, Southeast Asia, China, Japan and India. Moreover, this report focuses on the status and stance for major applications/end users, market share, sales volume and growth rate of these pumps in its major applications, such as Hospitals, Clinics and others.According to the study findings, due to a number of factors like growing prevalence of chronic diseases along with increasing geriatric population, increasing adoption of portable infusion pumps to reduce hospital expenditure and rapid increase in surgical procedural volumes, the global market has gained huge impetus in the year 2016. The researchers also estimated that the market will show a rapid growth in USD million by the end of 2022.Some of the major companies dealing in the analgesic infusion pumps market are:Smiths MedicalTaizhou PinqingBraunTerumoHospiraWoo Young MedicalBaxterKD ScientificFresenius KabiMedtronicCareFusion (BD)Summit Medical ProductsBrowse Full Report With TOC: http://www.marketresearchhub.com/report/global-analgesic-infusion-pumps-sales-market-report-2017-report.htmlIn the end, the report includes major sections which provide analysis on manufacturing cost, industrial chain, marketing strategy, market effect factors and the overall growth forecast for the period of 2017-2022.About Market Research HubMarket Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.Contact Us90 State StreetAlbany, NY 12207United StatesToll Free: 866-997-4948 (US-Canada)Tel: +1-518-621-2074Email: press@marketresearchhub.comFollow us on:Twitter: twitter.com/MktResearchHubLinkedIn: www.linkedin.com/company/market-research-hubFacebook: www.facebook.com/MarketResearchHub/ Click here to view the list of recent Press Releases from Market Research Hub


— Global Hemostatic Forceps Industry Report offers market overview, segmentation by types, application, countries, key manufactures, cost analysis, industrial chain, sourcing strategy, downstream buyers, marketing strategy analysis, distributors/traders, factors affecting market, forecast and other important information for key insight. Companies profiled in this report are Medline, B. Braun, CareFusion, Asa Dental, Sklar, Scanlan International, Shanghai Medical Instruments, Lawton, Hu-Friedy, Xinhua Surgical, Towne Brothers, Teleflex Medical, Delacroix Chevalier, YDM, M A Corporation, MedGyn Products, Inami, Ted Pella, Medicon eG, J & J Instruments, American Diagnostic in terms of Basic Information, Manufacturing Base, Sales Area and Its Competitors, Sales, Revenue, Price and Gross Margin (2012-2017). Split by Product Types, with sales, revenue, price, market share of each type, can be divided into • Halstead mosquito hemostatic forceps • Kelly and Crile hemostatic forceps • Rochester-Carmalt hemostatic forceps Split by applications, this report focuses on sales, market share and growth rate of Hemostatic Forceps in each application, can be divided into • Application 1 • Application 2 • Application 3 Purchase a copy of this report at: https://www.themarketreports.com/report/buy-now/424361 Table of Content: 1 Hemostatic Forceps Market Overview 2 Global Hemostatic Forceps Sales, Revenue (Value) and Market Share by Manufacturers 3 Global Hemostatic Forceps Sales, Revenue (Value) by Countries, Type and Application (2012-2017) 4 Global Hemostatic Forceps Manufacturers Profiles/Analysis 5 North America Hemostatic Forceps Sales, Revenue (Value) by Countries, Type and Application (2012-2017) 6 Latin America Hemostatic Forceps Sales, Revenue (Value) by Countries, Type and Application (2012-2017) 7 Europe Hemostatic Forceps Sales, Revenue (Value) by Countries, Type and Application (2012-2017) 8 Asia-Pacific Hemostatic Forceps Sales, Revenue (Value) by Countries, Type and Application (2012-2017) 9 Middle East and Africa Hemostatic Forceps Sales, Revenue (Value) by Countries, Type and Application (2012-2017) 10 Hemostatic Forceps Manufacturing Cost Analysis 11 Industrial Chain, Sourcing Strategy and Downstream Buyers 12 Marketing Strategy Analysis, Distributors/Traders 13 Market Effect Factors Analysis 14 Global Hemostatic Forceps Market Forecast (2017-2022) 15 Research Findings and Conclusion 16 Appendix Inquire more for more details about this report at: https://www.themarketreports.com/report/ask-your-query/424361 For more information, please visit https://www.themarketreports.com/report/2017-2022-global-top-countries-hemostatic-forceps-market-report


·         The global pneumatic nebulizers market was valued at USD 490.6 million in 2015 and is expected to reach a value of USD 893.9 million by 2025. ·         The introduction of new systems featuring aerosol drug delivery technology with minimal drug wastage is expected to drive the market growth. ·         Moreover, the clinical management system furnishes a single platform combining sleep and respiratory care, providing informatics and workflow intelligence for patients, providers, and payers. ·         Vented nebulizers dominated the product type segment in 2015 owing to their high availability and affordable cost. ·         North America is estimated to dominate the pneumatic nebulizers market in 2015. ·         Asia Pacific is the fastest growing market owing to its huge aging population base, increasing focus on preventive care, and government initiatives promoting technological innovations. The global pneumatic nebulizers market was valued at USD 490.6 million in 2015 and is expected to reach a value of USD 893.9 million by 2025. The expansion is attributed to the increasing geriatric population base along with the growing need for home healthcare portable devices. The introduction of new systems featuring aerosol drug delivery technology with minimal drug wastage is expected to drive the market growth. For instance, in May 2013, Parion Sciences in partnership with Cambridge Consultants developed a technology that delivers tiny saline droplets that infiltrate deep into the lungs. The trans-nasal pulmonary aerosol delivery device currently undergoing clinical trial is intended for the treatment of cystic fibrosis. Moreover, with the rising rate of hospital admissions and the resultant high expenditure, companies are encouraged to introduce home care devices that enable pre-hospitalization monitoring. Furthermore, the advent of integrated devices has empowered patients and physicians to share and access data on a single platform. For instance, in March 2016, Philips received 510 (K) clearance for its Care Orchestrator. The cloud-based technology is a clinical management software, which promotes homecare for sleep apnea and respiratory care patients. Moreover, the clinical management system furnishes a single platform combining sleep and respiratory care, providing informatics and workflow intelligence for patients, providers, and payers. Some of the major players operating include Omron Corporation, Philips Healthcare; PARI Pharma GmbH; GE Healthcare; Allied Healthcare; Becton, Dickinson and Company; Agilent Technologies; Medline Industries, Inc.; and Briggs Healthcare. Further Key Findings from the Study Suggest: Vented nebulizers dominated the product type segment in 2015 owing to their high availability and affordable cost. Moreover, industry contributors are introducing new solutions that enable patient data access in one single platform. In November 2015, CareFusion introduced a new respiratory solution at the American Association for Respiratory Care Congress. North America is estimated to dominate the pneumatic nebulizers market in 2015. The introduction of advanced technological devices and the supportive medical coverage offered in this region is expected to further fuel market growth. For instance, in March 2015, Sunovion Pharmaceuticals, Inc. announced the initiation of Phase III clinical trial for its SUN-101 solution using PARI Pharma's eFlow nebulizer system for COPD. Asia Pacific is the fastest growing market owing to its huge aging population base, increasing focus on preventive care, and government initiatives promoting technological innovations. In July 2015, Tribeca Care launched its online healthcare store to supply homecare respiratory products, wherein prominent medical brands such as Philips, Omron, Nidek, Karma, ResMed, and Vissco were brought under one roof. Read the full report: http://www.reportlinker.com/p04523008/Pneumatic-Nebulizers-Market-Analysis-By-Type-Vented-Breath-Actuated-By-Region-And-Segment-Forecasts.html About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. http://www.reportlinker.com To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/pneumatic-nebulizers-market-is-expected-to-expected-to-reach-a-value-of-usd-8939-million-by-2025-300461997.html


— In the past five years from 2012 to 2016, global Pulmonary Function Testing Systems production revenue market scale was from 264.16 million US dollars to $ 321.45 million. It is estimated to reach 336.10 million dollars by 2017 and 416.10 million dollars by 2022, with the CAGR of 4.36% in terms of revenue over the period 2017-2022. Companies profiled in this report are CareFusion(BD), Schiller, CHEST, COSMED, nSpire Health, NDD, MGC Diagnostics, Minato, Ganshorn, AESRI, Morgan Scientific, M&B, Sikeda, RSDQ and more. Analysis by Product Types, with production, revenue, price, market share and growth rate of each type, can be divided into • Portable PFT Systems • Complete PFT Systems Analysis by Applications, this report focuses on consumption, market share and growth rate of Pulmonary Function Testing Systems in each application, can be divided into • Hospitals • Physical Examination Center • Physician Groups • Other Table of Contents: 1 Pulmonary Function Testing Systems Market Overview 2 Global Pulmonary Function Testing Systems Market Competition by Manufacturers 3 Global Pulmonary Function Testing Systems Capacity, Production, Revenue (Value) by Regions (2012-2017) 4 Global Pulmonary Function Testing Systems Supply (Production), Consumption, Export, Import by Regions (2012-2017) 5 Global Pulmonary Function Testing Systems Production, Revenue (Value), Price Trend by Types 6 Global Pulmonary Function Testing Systems Market Analysis by Applications 7 Major Manufacturers Analysis of Pulmonary Function Testing Systems 8 Pulmonary Function Testing Systems Manufacturing Cost Analysis 9 Industrial Chain, Sourcing Strategy and Downstream Buyers 10 Marketing Strategy Analysis, Distributors/Traders 11 Market Effect Factors Analysis 12 Global Pulmonary Function Testing Systems Market Forecast (2017-2022) 13 Research Findings and Conclusion 14 Appendix Inquire more about this report at: https://www.themarketreports.com/report/ask-your-query/292798 For more information, please visit https://www.themarketreports.com/report/global-pulmonary-function-testing-systems-market-research-report-2017


News Article | May 22, 2017
Site: globenewswire.com

SAN DIEGO, May 22, 2017 (GLOBE NEWSWIRE) -- The MEPS Real-Time, Inc. (MEPS®) Board of Directors announced that Shariq Hussain is stepping down as Chief Executive Officer and the Board has named Gordon Krass as the company’s new CEO effective today. Following the transition, Hussain will assume the Chief Technology Officer role and will serve on the company’s board in an Emeritus advisory position.  Recently, health issues prompted Hussain to approach the Board to recommend a succession plan. "Our company’s evolution requires a level of focus I am unable to provide right now as I need to be personally focused on my own healing and rehabilitation,” Hussain said. “I’m confident we are in good hands with Gordon to support the success we’ve achieved to date and to lead the strategic growth plan we’ve outlined.” As CTO, Hussain will continue to guide product innovation for the company’s Intelliguard® RFID Solutions for both hospital and health system pharmacy operations, plus a growing solution portfolio for adjacent healthcare markets. Krass brings more than 25 years of executive experience with start-up and Fortune 500 companies in the medical device and telecommunications industries. Most recently, he served as President and Chief Client Officer of NobelBiz, a telecommunications and software company. Prior to NobelBiz, Krass spent 16-plus years with IVAC Corporation (ALARIS Medical Systems Inc./CareFusion Corp.), where he served in several leadership positions, including as Vice President of Marketing and Sales. Previously, Krass was Vice President of Sales and a member of the leadership team at LMA North America, Inc., a medical device company that introduced new technology into the anesthesia market. Under his leadership, LMA achieved more than 40 percent market share within five years. He was also an executive at Kinetic Surgical, a start-up medical device company that developed new surgical technology, and part of the executive team that negotiated the sale of the company to Cardinal Health, Inc. "I’m excited to be joining MEPS," Krass said. “The company has a strong technology foundation built on solid intellectual property. With our Intelliguard RFID Solutions already in use by more than 400 pharmaceutical, healthcare and life sciences partners, we are well positioned to lead ongoing innovation and value for our customers and growth for our employees and shareholders.” About MEPS Real-Time, Inc. and Intelliguard® RFID Solutions for Critical Inventory™ MEPS Real-Time, Inc. (mepsrealtime.com) is a leading innovator of Radio Frequency Identification (RFID) solutions for pharmacy inventory management applications. Intelliguard® RFID Solutions provide unparalleled real-time visibility of critical inventory in healthcare. We develop patented technology and processes with an unwavering commitment to accuracy to eliminate human error, improve cost control, reduce risk, and increase efficiency. Intelliguard® RFID Solutions include Kit and Tray Management, Linked Visibility Inventory System™ for the OR, Inventory Management, and Vendor Managed Inventory Systems. MEPS Real-Time® is a charter member of RAIN RFID global alliance.


News Article | May 22, 2017
Site: globenewswire.com

SAN DIEGO, May 22, 2017 (GLOBE NEWSWIRE) -- The MEPS Real-Time, Inc. (MEPS®) Board of Directors announced that Shariq Hussain is stepping down as Chief Executive Officer and the Board has named Gordon Krass as the company’s new CEO effective today. Following the transition, Hussain will assume the Chief Technology Officer role and will serve on the company’s board in an Emeritus advisory position.  Recently, health issues prompted Hussain to approach the Board to recommend a succession plan. "Our company’s evolution requires a level of focus I am unable to provide right now as I need to be personally focused on my own healing and rehabilitation,” Hussain said. “I’m confident we are in good hands with Gordon to support the success we’ve achieved to date and to lead the strategic growth plan we’ve outlined.” As CTO, Hussain will continue to guide product innovation for the company’s Intelliguard® RFID Solutions for both hospital and health system pharmacy operations, plus a growing solution portfolio for adjacent healthcare markets. Krass brings more than 25 years of executive experience with start-up and Fortune 500 companies in the medical device and telecommunications industries. Most recently, he served as President and Chief Client Officer of NobelBiz, a telecommunications and software company. Prior to NobelBiz, Krass spent 16-plus years with IVAC Corporation (ALARIS Medical Systems Inc./CareFusion Corp.), where he served in several leadership positions, including as Vice President of Marketing and Sales. Previously, Krass was Vice President of Sales and a member of the leadership team at LMA North America, Inc., a medical device company that introduced new technology into the anesthesia market. Under his leadership, LMA achieved more than 40 percent market share within five years. He was also an executive at Kinetic Surgical, a start-up medical device company that developed new surgical technology, and part of the executive team that negotiated the sale of the company to Cardinal Health, Inc. "I’m excited to be joining MEPS," Krass said. “The company has a strong technology foundation built on solid intellectual property. With our Intelliguard RFID Solutions already in use by more than 400 pharmaceutical, healthcare and life sciences partners, we are well positioned to lead ongoing innovation and value for our customers and growth for our employees and shareholders.” About MEPS Real-Time, Inc. and Intelliguard® RFID Solutions for Critical Inventory™ MEPS Real-Time, Inc. (mepsrealtime.com) is a leading innovator of Radio Frequency Identification (RFID) solutions for pharmacy inventory management applications. Intelliguard® RFID Solutions provide unparalleled real-time visibility of critical inventory in healthcare. We develop patented technology and processes with an unwavering commitment to accuracy to eliminate human error, improve cost control, reduce risk, and increase efficiency. Intelliguard® RFID Solutions include Kit and Tray Management, Linked Visibility Inventory System™ for the OR, Inventory Management, and Vendor Managed Inventory Systems. MEPS Real-Time® is a charter member of RAIN RFID global alliance.


News Article | May 22, 2017
Site: globenewswire.com

SAN DIEGO, May 22, 2017 (GLOBE NEWSWIRE) -- The MEPS Real-Time, Inc. (MEPS®) Board of Directors announced that Shariq Hussain is stepping down as Chief Executive Officer and the Board has named Gordon Krass as the company’s new CEO effective today. Following the transition, Hussain will assume the Chief Technology Officer role and will serve on the company’s board in an Emeritus advisory position.  Recently, health issues prompted Hussain to approach the Board to recommend a succession plan. "Our company’s evolution requires a level of focus I am unable to provide right now as I need to be personally focused on my own healing and rehabilitation,” Hussain said. “I’m confident we are in good hands with Gordon to support the success we’ve achieved to date and to lead the strategic growth plan we’ve outlined.” As CTO, Hussain will continue to guide product innovation for the company’s Intelliguard® RFID Solutions for both hospital and health system pharmacy operations, plus a growing solution portfolio for adjacent healthcare markets. Krass brings more than 25 years of executive experience with start-up and Fortune 500 companies in the medical device and telecommunications industries. Most recently, he served as President and Chief Client Officer of NobelBiz, a telecommunications and software company. Prior to NobelBiz, Krass spent 16-plus years with IVAC Corporation (ALARIS Medical Systems Inc./CareFusion Corp.), where he served in several leadership positions, including as Vice President of Marketing and Sales. Previously, Krass was Vice President of Sales and a member of the leadership team at LMA North America, Inc., a medical device company that introduced new technology into the anesthesia market. Under his leadership, LMA achieved more than 40 percent market share within five years. He was also an executive at Kinetic Surgical, a start-up medical device company that developed new surgical technology, and part of the executive team that negotiated the sale of the company to Cardinal Health, Inc. "I’m excited to be joining MEPS," Krass said. “The company has a strong technology foundation built on solid intellectual property. With our Intelliguard RFID Solutions already in use by more than 400 pharmaceutical, healthcare and life sciences partners, we are well positioned to lead ongoing innovation and value for our customers and growth for our employees and shareholders.” About MEPS Real-Time, Inc. and Intelliguard® RFID Solutions for Critical Inventory™ MEPS Real-Time, Inc. (mepsrealtime.com) is a leading innovator of Radio Frequency Identification (RFID) solutions for pharmacy inventory management applications. Intelliguard® RFID Solutions provide unparalleled real-time visibility of critical inventory in healthcare. We develop patented technology and processes with an unwavering commitment to accuracy to eliminate human error, improve cost control, reduce risk, and increase efficiency. Intelliguard® RFID Solutions include Kit and Tray Management, Linked Visibility Inventory System™ for the OR, Inventory Management, and Vendor Managed Inventory Systems. MEPS Real-Time® is a charter member of RAIN RFID global alliance.


News Article | May 26, 2017
Site: www.prweb.com

Somnoware, a leading provider of digital health technology, announces the integration of the CareFusion NOX-T3 portable sleep monitor with its Somnoware Sleep Device Interface (SDI). Somnoware SDI is a sleep device integration plugin that provides a consistent, browser-based interface for diagnostic device operations. With this platform, initializing devices and importing studies are just one-click operations. This plugin streamlines the user experience when conducting home sleep studies and allows for automated home sleep testing (HST) device inventory management. After a sleep study is completed, the plugin automatically uploads study data to the Somnoware cloud and the device becomes available for the next patient. The study import operation is automatic without requiring any user input or barcode scanning, minimizing potential typing and device assignment errors. When a report is ready for interpretation, the physician receives an email notification. By having access to the Somnoware platform, sleep center staff can easily schedule in-lab and home tests across various facilities, as well as quickly configure sleep devices and track inventory. Physicians also have easy access to test results and CPAP adherence data via the web browser. They can read the diagnosis and titration reports, and implement strategies for increasing therapy adherence. The overall use of this platform results in a significant reduction in interpretation times and enables better patient care. “We are very excited about the integration of CareFusion NOX-T3 with Somnoware. This integration significantly augments the Noxturnal user experience by delivering automation to increase sleep center efficiency and lower error rates,” according to Jinesh Jain, Director of Clinical Technology at Somnoware. As the industry’s leading sleep health management platform, Somnoware is currently used by one in five sleep physicians in the United States. It is available in two versions—Somnoware for Physicians and Somnoware for Sleep Centers. Physicians get instant access to sleep test data, e-signature capability, one-click DME ordering, CPAP compliance data, and the ability to conduct end-to-end patient care management. Sleep centers automate their complete workflow including scheduling at multiple centers, inventory management, automated reporting, therapy ordering, and AASM accreditation. To learn more about Somnoware, please contact Raj Misra at media(at)Somnoware(dot)com. About Somnoware Somnoware is transforming sleep health management by accelerating diagnostics and increasing therapy adherence. It automates sleep testing processes, provides actionable data and predictive insights to physicians, and drives patient engagement. Our customer base includes leading health systems, independent sleep centers, and sleep services companies. Somnoware is headquartered in Santa Clara, California. For more information, please visit http://www.somnoware.com or follow us on twitter @somnoware. Disclaimer: CareFusion and NOX-T3 are registered trademarks of BD in all countries. Noxturnal Software System is a registered trademark of Nox Medical in all countries. All other product and company names are trademarks or registered trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them.


— Raising birth rates across the globe, growing incidence of neonatal hospital-acquired infections, and growing healthcare awareness are the factors boosting the market growth during the forecast period. In addition, favorable initiatives by government and NGO’s, increasing technological advanced products are fuelling the market growth. On the other hand, strict regulations for new product approvals and expensive neonatal care equipments are the constraints hindering the market growth. By fetal equipment, ultrasound devices segment is expected to dominate the global market with a higher market share over the forecast period. Fetal monitors are estimated to contribute the higher CAGR due to its usage in finding the fetus heart rate at the time of pregnancy and labor. North America is the largest market owing to the adoption of advanced infrastructure and awareness about technological advancements. Moreover, the Asia Pacific is likely to report the highest CAGR during the forecast period, driven by the high birth rate in China and India. Some of the key players in global Fetal and Neonatal Care Equipment market include Atom Medical Corporation, Becton, Dickinson and Company, CareFusion Corporation, Cooper Surgical, Inc., Covidien PLC, Drägerwerk AG & Co. KGAA, Fisher & Paykel Healthcare Corporation Limited, FUJIFILM SonoSite, Inc., Ge Healthcare (A Division of General Electric Company), Getinge AB, Masimo Corporation, Medtronic Public Limited Company, Natus Medical Incorporated, Nonin Medical, Inc., Philips Healthcare (A Division of Koninklijke Philips N.V.), and Phoenix Medical Systems Pvt. Ltd. Regions Covered: • North America o US o Canada o Mexico • Europe o Germany o France o Italy o UK o Spain o Rest of Europe • Asia Pacific o Japan o China o India o Australia o New Zealand o Rest of Asia Pacific • Rest of the World o Middle East o Brazil o Argentina o South Africa o Egypt What our report offers: - Market share assessments for the regional and country level segments - Market share analysis of the top industry players - Strategic recommendations for the new entrants - Market forecasts for a minimum of 6 years of all the mentioned segments, sub segments and the regional markets - Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) - Strategic recommendations in key business segments based on the market estimations - Competitive landscaping mapping the key common trends - Company profiling with detailed strategies, financials, and recent developments - Supply chain trends mapping the latest technological advancements About Stratistics MRC We offer wide spectrum of research and consulting services with in-depth knowledge of different industries. We are known for customized research services, consulting services and Full Time Equivalent (FTE) services in the research world. We explore the market trends and draw our insights with valid assessments and analytical views. We use advanced techniques and tools among the quantitative and qualitative methodologies to identify the market trends. Our research reports and publications are routed to help our clients to design their business models and enhance their business growth in the competitive market scenario. We have a strong team with hand-picked consultants including project managers, implementers, industry experts, researchers, research evaluators and analysts with years of experience in delivering the complex projects. For more information, please visit http://www.strategymrc.com/

Loading CareFusion collaborators
Loading CareFusion collaborators